Sample Request

Global Celiac Disease Treatment Pipeline Drug Evaluation Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

SELECT LICENSE:

Published on 09/07/2021| Code: MAR41115D| Category: Utilities| Total Pages: 130

Based on the Celiac Disease Treatment Pipeline Drug Evaluation market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Celiac Disease Treatment Pipeline Drug Evaluation market covered in Chapter 5:

Selecta Biosciences
Takeda Pharmaceuticals (PvP Biologics)
BioLineRx
ImmunogenX
Calypso Biotech
ImmusanT
Amgen
Sitari Pharma
Mayo Clinic
Innovate Biopharmaceuticals
Provention Bio
Zedira
Anokion
Bioniz Therapeutics
9 Meters Biopharma
ActoBio Therapeutics

In Chapter 6, on the basis of types, the Celiac Disease Treatment Pipeline Drug Evaluation market from 2015 to 2025 is primarily split into:

Oral
Parenteral

In Chapter 7, on the basis of applications, the Celiac Disease Treatment Pipeline Drug Evaluation market from 2015 to 2025 covers:

Preclinical
Phase 1
Phase 2
Phase 3
Phase 4

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content

1 Market Overview

1.1 Product Definition and Market Characteristics

1.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Size

1.3 Market Segmentation

1.4 Global Macroeconomic Analysis

1.5 SWOT Analysis

2. Market Dynamics

2.1 Market Drivers

2.2 Market Constraints and Challenges

2.3 Emerging Market Trends

2.4 Impact of COVID-19

2.4.1 Short-term Impact

2.4.2 Long-term Impact

3 Associated Industry Assessment

3.1 Supply Chain Analysis

3.2 Industry Active Participants

3.2.1 Suppliers of Raw Materials

3.2.2 Key Distributors/Retailers

3.3 Alternative Analysis

3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape

4.1 Industry Leading Players

4.2 Industry News

4.2.1 Key Product Launch News

4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies

5.1 Selecta Biosciences
5.1.1 Selecta Biosciences Company Profile
5.1.2 Selecta Biosciences Business Overview
5.1.3 Selecta Biosciences Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Selecta Biosciences Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.2 Takeda Pharmaceuticals (PvP Biologics)
5.2.1 Takeda Pharmaceuticals (PvP Biologics) Company Profile
5.2.2 Takeda Pharmaceuticals (PvP Biologics) Business Overview
5.2.3 Takeda Pharmaceuticals (PvP Biologics) Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Takeda Pharmaceuticals (PvP Biologics) Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.3 BioLineRx
5.3.1 BioLineRx Company Profile
5.3.2 BioLineRx Business Overview
5.3.3 BioLineRx Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 BioLineRx Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.4 ImmunogenX
5.4.1 ImmunogenX Company Profile
5.4.2 ImmunogenX Business Overview
5.4.3 ImmunogenX Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 ImmunogenX Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.5 Calypso Biotech
5.5.1 Calypso Biotech Company Profile
5.5.2 Calypso Biotech Business Overview
5.5.3 Calypso Biotech Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 Calypso Biotech Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.6 ImmusanT
5.6.1 ImmusanT Company Profile
5.6.2 ImmusanT Business Overview
5.6.3 ImmusanT Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 ImmusanT Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.7 Amgen
5.7.1 Amgen Company Profile
5.7.2 Amgen Business Overview
5.7.3 Amgen Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Amgen Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.8 Sitari Pharma
5.8.1 Sitari Pharma Company Profile
5.8.2 Sitari Pharma Business Overview
5.8.3 Sitari Pharma Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Sitari Pharma Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.9 Mayo Clinic
5.9.1 Mayo Clinic Company Profile
5.9.2 Mayo Clinic Business Overview
5.9.3 Mayo Clinic Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Mayo Clinic Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.10 Innovate Biopharmaceuticals
5.10.1 Innovate Biopharmaceuticals Company Profile
5.10.2 Innovate Biopharmaceuticals Business Overview
5.10.3 Innovate Biopharmaceuticals Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Innovate Biopharmaceuticals Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.11 Provention Bio
5.11.1 Provention Bio Company Profile
5.11.2 Provention Bio Business Overview
5.11.3 Provention Bio Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Provention Bio Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.12 Zedira
5.12.1 Zedira Company Profile
5.12.2 Zedira Business Overview
5.12.3 Zedira Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Zedira Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.13 Anokion
5.13.1 Anokion Company Profile
5.13.2 Anokion Business Overview
5.13.3 Anokion Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Anokion Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.14 Bioniz Therapeutics
5.14.1 Bioniz Therapeutics Company Profile
5.14.2 Bioniz Therapeutics Business Overview
5.14.3 Bioniz Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Bioniz Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.15 9 Meters Biopharma
5.15.1 9 Meters Biopharma Company Profile
5.15.2 9 Meters Biopharma Business Overview
5.15.3 9 Meters Biopharma Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 9 Meters Biopharma Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction
5.16 ActoBio Therapeutics
5.16.1 ActoBio Therapeutics Company Profile
5.16.2 ActoBio Therapeutics Business Overview
5.16.3 ActoBio Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 ActoBio Therapeutics Celiac Disease Treatment Pipeline Drug Evaluation Products Introduction

6 Market Analysis and Forecast, By Product Types

6.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue and Market Share by Types (2015-2020)

6.1.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales and Market Share by Types (2015-2020)

6.1.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue and Market Share by Types (2015-2020)

6.1.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Price by Types (2015-2020)

6.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast by Types (2020-2025)

6.2.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Sales and Market Share by Types (2020-2025)

6.2.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Revenue and Market Share by Types (2020-2025)

6.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Price and Growth Rate by Types (2015-2020)

6.3.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Price and Growth Rate of Oral
6.3.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Price and Growth Rate of Parenteral
6.4 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Sales Forecast, by Types (2020-2025)

6.4.1 Oral Market Revenue and Sales Forecast (2020-2025)
6.4.2 Parenteral Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications

7.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales, Revenue and Market Share by Applications (2015-2020)

7.1.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales and Market Share by Applications (2015-2020)

7.1.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue and Market Share by Applications (2015-2020)

7.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast by Applications (2020-2025)

7.2.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Sales and Market Share by Applications (2020-2025)

7.2.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast Revenue and Market Share by Applications (2020-2025)

7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)

7.3.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Preclinical (2015-2020)
7.3.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 1 (2015-2020)
7.3.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 2 (2015-2020)
7.3.4 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 3 (2015-2020)
7.3.5 Global Celiac Disease Treatment Pipeline Drug Evaluation Revenue, Sales and Growth Rate of Phase 4 (2015-2020)
7.4 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Sales Forecast, by Applications (2020-2025)

7.4.1 Preclinical Market Revenue and Sales Forecast (2020-2025)
7.4.2 Phase 1 Market Revenue and Sales Forecast (2020-2025)
7.4.3 Phase 2 Market Revenue and Sales Forecast (2020-2025)
7.4.4 Phase 3 Market Revenue and Sales Forecast (2020-2025)
7.4.5 Phase 4 Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions

8.1 Global Celiac Disease Treatment Pipeline Drug Evaluation Sales by Regions (2015-2020)

8.2 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue by Regions (2015-2020)

8.3 Global Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast by Regions (2020-2025)

9 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis

9.1 Market Overview and Prospect Analysis

9.2 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)

9.3 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)

9.4 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast

9.5 The Influence of COVID-19 on North America Market

9.6 North America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country

9.6.1 U.S. Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

9.6.2 Canada Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

9.6.3 Mexico Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

10 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis

10.1 Market Overview and Prospect Analysis

10.2 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)

10.3 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)

10.4 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast

10.5 The Influence of COVID-19 on Europe Market

10.6 Europe Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country

10.6.1 Germany Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

10.6.2 United Kingdom Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

10.6.3 France Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

10.6.4 Italy Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

10.6.5 Spain Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

10.6.6 Russia Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

11 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis

11.1 Market Overview and Prospect Analysis

11.2 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)

11.3 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)

11.4 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast

11.5 The Influence of COVID-19 on Asia Pacific Market

11.6 Asia-Pacific Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country

11.6.1 China Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

11.6.2 Japan Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

11.6.3 South Korea Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

11.6.4 Australia Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

11.6.5 India Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

12 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis

12.1 Market Overview and Prospect Analysis

12.2 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)

12.3 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)

12.4 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast

12.5 The Influence of COVID-19 on South America Market

12.6 South America Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country

12.6.1 Brazil Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

12.6.2 Argentina Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

12.6.3 Columbia Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

13 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis

13.1 Market Overview and Prospect Analysis

13.2 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Sales and Growth Rate (2015-2020)

13.3 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Revenue and Growth Rate (2015-2020)

13.4 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Forecast

13.5 The Influence of COVID-19 on Middle East and Africa Market

13.6 Middle East and Africa Celiac Disease Treatment Pipeline Drug Evaluation Market Analysis by Country

13.6.1 UAE Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

13.6.2 Egypt Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

13.6.3 South Africa Celiac Disease Treatment Pipeline Drug Evaluation Sales and Growth Rate

14 Conclusions and Recommendations

14.1 Key Market Findings and Prospects

14.2 Advice for Investors

15 Appendix

15.1 Methodology

15.2 Research Data Source

Our Clients

BIC
Suntory Holdings
Continental AG
Ernst Klett
felix
IF Logo
ITC logo
jc
KB
KKR
LR
LSC
Prospect
SRG
Sumitomo
Taichin logo
The Cleanest Way
Meat & Livestock Australia Limited
LEK
IFFCO
STTS
Laundry Capital LLC
Chippenhook Corporation
SAB
IJIN
Hooton
Medica
Medalliacne
Shanghai Chenzhu Instrument Co., Ltd.
Sanofi
Kleen Linnebo und Partner GbR
Bond-Pro, Inc.
E&L Faster Food Imports Inc.
Okinawa Institute of Science and Technology
Mizuno Corp
AutoX
A.JAFFE
Aaga Marketing
AGRIC SA
Alcimed
AMSEC
Aquanova
AYTB Industrial
Bain & Company
Brooks Life Sciences
Cirona Labs
CMV Informatics
CONNEMARAORGANIC SEAWEED COMPANY
Desmet Ballestra Group
Dine4Fit, a.s.
Dream Incubator Vietnam Joint Stock Company
DSM
Eastman Chemical
Edwards Vacuum
Emerson
Getinge
Hello Flexibles
Industrie Beteiligungs Gesellschaft IBG
Inscripta, Inc.
JLL Technologies
Kari-Out
Marafie Engineering Co
Monitor Deloitte
Mossif3
mpumalanga stainless initiative
Nextteq, LLC
Pattern
Phizzle
Phronesis Partners Pte. Ltd.
PSP Specialties
Reno Refractories, Inc.
Roche Diagnostics International Ltd.
Rockfield Medical Device
RSG Media
Sealed Air
Sutton Capital Partners, Inc
Tenshi LifeCare Pvt Ltd (Velbiom Probiotics PVt Ltd)
The Crocodile Integrated Marketing Ltd
Tomorrow.io
UL
Vibrant Marketing
Wild Republic
ams OSRAM
Atelerix Life Sciences Inc
Beckman Coulter Life Sciences
BIOTECH VISION CARE PVT. LTD
Chiripal
Circle NVI
Freudenberg Filtration Technologies SE & Co. KG
FTA HSRP Solutions Pvt Ltd
Goetz Partners
Good clean love
Hasso Plattner d-school at UCT
InnoFaith Beauty Sciences
INSALA
Kukuza Consulting
MilliporeSigma
Panasonic Industry Europe
Quintus Technologies
Renesas
Roche Diagnostics International Ltd.
Timee, Inc.
YCP Solidiance
Graffer
Magnus
Pantex Ennerflo
The Japan Association of Bonded Magnetic Materials
SIS
Elian
RS Connect
3 Hunters Talent Solutions LATAM
Atelerix Life Sciences Inc
David Clark
DSGLOBAL CO.,LTD.
Hitotsubashi University
kovis-group
Saunacore
Suez Consulting
WestRock
Medeon Biodesign
Power Transmission Consulting, PTC AB
Sint Maartenskliniek
ITW Specialty Films
American Fuji Seal, Inc.
Tag-consultants.com
HAZEMAG Systems GmbH
Dabur International
lippert componentrs
Aelea Commodities Private Limited
ERRIA A/S
Chiripal Group
Capstone Partners
VETTEX SRL
Ægir Advisory Services
John Deere
ADTEC Plasma Technology
Cairneagle
Mckinsey
Panasonic Consumer Electronics Company
ACT
Mele & Co
SAZKA a.s.
THIN
Assurance Services International
Intro-act Inc
School of Health Sciences/Democritus University of Thrace
W.L.Gore
Nippon Steel Co.
AFB International
986 Labs
Bamboi
Zaptin Communications LLC

Need Help?

Please fill form below:

Contact Us

99 WALL STREET #2124 NEW YORK, NY 10005